Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
We've been funding research into secondary breast cancer for over 2 decades. See the difference it’s making.
Scientists at the Breast Cancer Now Toby Robins Research Centre at the Institute of Cancer Research, London have identified a new group of people who may benefit from PARP inhibitors.
Leading a healthy lifestyle after a breast cancer diagnosis and treatment can help with this. So, our researchers are looking at ways to better support women with this.
Researchers have developed an artificial intelligence model that can predict if triple negative breast cancer will spread.
Our scientists have uncovered a way in which breast cancer cells ‘wake-up’ and form secondary tumours in the lungs.
Breast cancer screening is an important tool for early detection. But what does screening currently look like? And how could it be improved?
Ductal Carcinoma in Situ (DCIS) is an early form of breast cancer. With DCIS, cancer cells are present in the breast duct, but they can’t spread to the surrounding breast tissue.
We’re reporting on the San Antonio Breast Cancer Symposium 2022, the largest breast cancer conference in the world.
Edd, our research communications officer, attended the symposium. He shares his highlights of days 1 to 4.
Today we’re celebrating the International Day of Women and Girls in Science! So, we're shining a spotlight on 3 of our amazing researchers.